• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

新型冠状病毒肺炎后出现间歇性慢性休止期脱发并伴有异常皮肤镜表现

Intermittent chronic telogen effluvium with an unusual dermoscopic finding following COVID-19.

作者信息

Saki Nasrin, Aslani Fatemeh Sari, Sepaskhah Mozhdeh, Shafiei Mohadese, Alavizadeh Sara, Hosseini Seyed Ali, Asl Fatemeh Ansari, Ahramiyanpour Najmeh

机构信息

Molecular Dermatology Research Center Shiraz University of Medical Sciences Shiraz Iran.

Department of Dermatology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran.

出版信息

Clin Case Rep. 2022 Aug 9;10(8):e6228. doi: 10.1002/ccr3.6228. eCollection 2022 Aug.

DOI:10.1002/ccr3.6228
PMID:35957778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9361802/
Abstract

Various conditions, including infections, can cause telogen effluvium (TE). One of them is coronavirus disease 2019 (COVID-19), where hair loss usually begins between 2 and 12 weeks after the illness. TE can be acute or chronic, and the chronic type can be intermittent. Here, we present the case of a 17-year-old girl with severe and widespread hair loss following an upper respiratory infection suspected to be COVID-19, with the patient having a history of such attacks since childhood. Evidence from biopsy and dermoscopy indicated a diagnosis of TE.

摘要

包括感染在内的多种情况可导致休止期脱发（TE）。其中之一是2019冠状病毒病（COVID-19），脱发通常在患病后2至12周开始。TE可分为急性或慢性，慢性类型可能是间歇性的。在此，我们报告一例17岁女孩的病例，该女孩在疑似COVID-19的上呼吸道感染后出现严重且广泛的脱发，患者自童年起就有此类发作史。活检和皮肤镜检查的证据表明诊断为休止期脱发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552c/9361802/2541caff21fd/CCR3-10-e6228-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552c/9361802/87cd83599c5a/CCR3-10-e6228-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552c/9361802/35bafd1123b4/CCR3-10-e6228-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552c/9361802/8fec53eda82e/CCR3-10-e6228-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552c/9361802/2541caff21fd/CCR3-10-e6228-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552c/9361802/87cd83599c5a/CCR3-10-e6228-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552c/9361802/35bafd1123b4/CCR3-10-e6228-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552c/9361802/8fec53eda82e/CCR3-10-e6228-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552c/9361802/2541caff21fd/CCR3-10-e6228-g005.jpg

相似文献

1
Intermittent chronic telogen effluvium with an unusual dermoscopic finding following COVID-19.新型冠状病毒肺炎后出现间歇性慢性休止期脱发并伴有异常皮肤镜表现
Clin Case Rep. 2022 Aug 9;10(8):e6228. doi: 10.1002/ccr3.6228. eCollection 2022 Aug.
2
Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID-19 telogen effluvium?大流行期间休止期脱发患者的评估：单核细胞是否是新冠后休止期脱发的原因？
J Cosmet Dermatol. 2022 May;21(5):1809-1815. doi: 10.1111/jocd.14883. Epub 2022 Feb 28.
3
Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management.新冠病毒感染患者的拔毛癖和休止期脱发：一项关于诊断和管理的国际专家意见调查结果
JAAD Int. 2021 Dec;5:11-18. doi: 10.1016/j.jdin.2021.07.006. Epub 2021 Aug 3.
4
A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation.急性休止期脱发的系统评价，一种令人痛苦的新冠后表现。
J Med Virol. 2022 Apr;94(4):1391-1401. doi: 10.1002/jmv.27534. Epub 2021 Dec 28.
5
COVID-19 infection is a major cause of acute telogen effluvium.COVID-19 感染是急性休止期脱发的主要原因。
Ir J Med Sci. 2022 Aug;191(4):1677-1681. doi: 10.1007/s11845-021-02754-5. Epub 2021 Aug 31.
6
Telogen effluvium and COVID-19: a cross-sectional study.休止期脱发与 COVID-19：一项横断面研究。
Eur Rev Med Pharmacol Sci. 2023 Aug;27(16):7823-7830. doi: 10.26355/eurrev_202308_33437.
7
Comparison of Dermoscopic Findings in Female Androgenetic Alopecia and Telogen Effluvium and Female Controls in a Tertiary Care Center.三级医疗中心女性雄激素性脱发、休止期脱发及女性对照的皮肤镜检查结果比较
J Clin Aesthet Dermatol. 2022 May;15(5):29-34.
8
Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms.新型冠状病毒感染后的休止期脱发：一系列病例及可能的发病机制
Skin Appendage Disord. 2021 Jul 8;21(5):1-5. doi: 10.1159/000517223.
9
Red LED light therapy for telogen effluvium in the course of long COVID in patients with and without androgenetic alopecia.红色发光二极管光疗法治疗患有和不患有雄激素性脱发的长期新冠患者的休止期脱发
Ann Agric Environ Med. 2024 Jun 27;31(2):239-247. doi: 10.26444/aaem/177238. Epub 2024 Jan 8.
10
COVID-19 induced telogen effluvium.COVID-19 引发的休止期脱发。
Dermatol Ther. 2021 Nov;34(6):e15175. doi: 10.1111/dth.15175. Epub 2021 Nov 6.

引用本文的文献

1
[Review of the post-COVID-19 syndrome associated to acute telogen effluvium].[与急性休止期脱发相关的新冠后综合征综述]
Rev Med Inst Mex Seguro Soc. 2023 Jul 31;61(4):496-501. doi: 10.5281/zenodo.8200471.
2
SARS-CoV-2 Infection-A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation.新型冠状病毒感染——休止期脱发的触发因素：文献综述及基于病例的临床评估指南
Life (Basel). 2023 Jul 18;13(7):1576. doi: 10.3390/life13071576.

本文引用的文献

1
A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation.急性休止期脱发的系统评价，一种令人痛苦的新冠后表现。
J Med Virol. 2022 Apr;94(4):1391-1401. doi: 10.1002/jmv.27534. Epub 2021 Dec 28.
2
COVID-19 induced telogen effluvium.COVID-19 引发的休止期脱发。
Dermatol Ther. 2021 Nov;34(6):e15175. doi: 10.1111/dth.15175. Epub 2021 Nov 6.
3
Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms.新型冠状病毒感染后的休止期脱发：一系列病例及可能的发病机制
Skin Appendage Disord. 2021 Jul 8;21(5):1-5. doi: 10.1159/000517223.
4
Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management.新冠病毒感染患者的拔毛癖和休止期脱发：一项关于诊断和管理的国际专家意见调查结果
JAAD Int. 2021 Dec;5:11-18. doi: 10.1016/j.jdin.2021.07.006. Epub 2021 Aug 3.
5
The development of dermatologic diseases in patients recovered from COVID-19.新冠康复患者皮肤病的发展情况。
Dermatol Ther. 2021 Mar;34(2):e14791. doi: 10.1111/dth.14791. Epub 2021 Feb 4.
6
Telogen effluvium associated with COVID-19 infection.与 COVID-19 感染相关的休止期脱发。
Dermatol Ther. 2021 Mar;34(2):e14761. doi: 10.1111/dth.14761. Epub 2021 Jan 14.
7
A surge in the incidence of telogen effluvium in minority predominant communities heavily impacted by COVID-19.在受新冠疫情严重影响的少数族裔占主导的社区中，休止期脱发的发病率激增。
J Am Acad Dermatol. 2021 Mar;84(3):773-775. doi: 10.1016/j.jaad.2020.11.032. Epub 2020 Dec 10.
8
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience.与严重 SARS-CoV-2 感染后相关的休止期脱发：临床特征和我们的治疗经验。
Dermatol Ther. 2021 Jan;34(1):e14547. doi: 10.1111/dth.14547. Epub 2020 Nov 23.
9
Relative changes in the pattern of diseases presenting in dermatology outpatient clinic in the era of the COVID-19 pandemic.在 COVID-19 大流行时代，皮肤科门诊疾病发病模式的相对变化。
Dermatol Ther. 2020 Nov;33(6):e14096. doi: 10.1111/dth.14096. Epub 2020 Aug 14.
10
Telogen Effluvium: A Review of the Literature.休止期脱发：文献综述
Cureus. 2020 May 27;12(5):e8320. doi: 10.7759/cureus.8320.